First Page | Document Content | |
---|---|---|
Date: 2016-07-02 14:50:25Health Medicine Breakthrough therapy Specialty drugs Gilead Sciences Healthcare-associated infections Cyclopropanes Sofosbuvir Ledipasvir National Institute for Health and Care Excellence Hepatitis National Health Service | Microsoft Word - GILEAD BRIEFINGAdd to Reading ListSource URL: www.ukts.orgDownload Document from Source WebsiteFile Size: 102,77 KBShare Document on Facebook |
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and Social Care Directorate Implementation Strategy Group Terms of reference 2016 Background NICE’s business plan sets a strategic objective for the Institute toDocID: 1v8RM - View Document | |
A consultation to inform an update of the NHS Constitution: feedback report July 2015DocID: 1r4BW - View Document | |
Microsoft Word - GILEAD BRIEFINGDocID: 1r2Vm - View Document | |
Microsoft Word - valuing healthDocID: 1qVy7 - View Document | |
NATIONAL INFERTILITY GROUP REPORT MARCH 2016 417695_Fertility_p10.indd 1DocID: 1qTLT - View Document |